stockrowBausch + Lomb Corporation
BLCO Healthcare Medical Instruments & Supplies
Bausch + Lomb Corporation’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 6.47% from fiscal 2024.
- Revenue
- +7.34%
- EPS
- +222.4%
- Free cash flow
- +182.5%
- Total debt
- +2.93%
Quarter to September 2026, against a year earlier
Follow BLCO
Alert me
Bausch + Lomb Corporation (BLCO) Current ratio
Bausch + Lomb Corporation's current ratio at the end of the quarter to 30 September 2026 was 1.6×, up 0.0× from fiscal 2025 (1.6×). Over the past ten years it has ranged from 1.5× (fiscal 2021) to 1.8× (fiscal 2020); the current reading is higher than 33% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 1.6× | (3.34%) |
| FY2024 | 1.6× | (7.62%) |
| FY2023 | 1.7× | 5.31% |
| FY2022 | 1.6× | 10.84% |
| FY2021 | 1.5× | (18.24%) |
| FY2020 | 1.8× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 1.6× | 0.82% |
| Jun 2026 | 1.5× | 1.36% |
| Mar 2026 | 1.5× | (1.63%) |
| Dec 2025 | 1.6× | 2.97% |
| 17 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| RGEN Repligen Corporation compare | 9.9× |
| MMSI Merit Medical Systems, Inc. compare | 4.5× |
| TFX Teleflex Incorporated compare | 2.6× |
| AVTR Avantor, Inc. compare | 1.9× |
| MMED MiniMed Group, Inc. compare | 1.8× |
| BLCO Bausch + Lomb Corporation | 1.6× |
| ATR AptarGroup, Inc. compare | 1.5× |
| ALGN Align Technology, Inc. compare | 1.4× |
| COO The Cooper Companies, Inc. compare | 1.2× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on BLCO
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement